Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: Lessons for the future in pathogenesis

Respiratory Research

Volumn 3, Issue , 2001, Pages

  Eddahibi, Saadia ^a   Adnot, Serge ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Anorexigens; Appetite suppressants; Pulmonary hypertension; Pulmonary vascular smooth muscle cells; Serotonin transporter

Indexed keywords

AMINOREX; ANOREXIGENIC AGENT; CHLORPHENTERMINE; DEXFENFLURAMINE; FENFLURAMINE; PHENTERMINE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CELL GROWTH; DRUG INDUCED DISEASE; DRUG MECHANISM; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MITOGENICITY; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RISK ASSESSMENT; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; SMOOTH MUSCLE FIBER;

EID: 25444451561     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/rr181     Document Type: Article

References (27)

1. Kay JM, Smith P, Heath D: Aminorex and the pulmonary circulation. Thorax 1971, 26:262-273.
2. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Begaud B: Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996, 335:609-616.
3. Fishman AP: Aminorex to fen/phen: an epidemic foretold. Circulation 1999, 99:156-161.
4. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S: Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin. Circ Res 1999, 84:329-336.
5. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Blakely RD: Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning expression, and chormosomal localization. Proc Natl Acad Sci USA 1993, 90:2542-2546.
6. Rothman RB, Ayestas MA, Dersch CM, Baumann MH: Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension. Circulation 1999, 100:869-875.
7. Rubin LJ: Primary pulmonary hypertension. N Engl J Med 1997, 336:111-117.
8. Lee SL, Wang WW, Moore BJ, Fanburg BL: Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cell in culture. Circ Res 1991, 68:1362-1368.
9. Lee S, Wang W, Fanburg BL: Dexfenfluramine as a mitogen signal via the formation of superoxide anion. FASEB J 2001, 15:1324-1325.
10. Eddahibi S, Hanoun N, Lanfumey L, Lesch K, Raffestin B, Hamon M, Adnot S: Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 2000, 105:1555-1562.
11. Eddahibi S, Adnot S, Frisdal E, Levame M, Hamon M, Raffestin B: Dexfenfluramine-associated changes in 5-hydroxytryptamine transporter expression and development of hypoxic pulmonary hypertension in rats. J Pharmacol Exp Ther 2001, 297: 148-154.
12. Eddahibi S, Chouaid C, Sediame S, Housset B, Hamon M, Adnots S: Serotonin uptake and citalopram binding in platelets from patients with chronic pulmonary hypertension [abstract]. Am J Respir Crit Care Med 1999, 159:A165.
13. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S: Hyperplasia of pulmonary artery smooth muscle cells causally related to overexpression of the serotonin transporter in primary pulmonary hypertension. J Clin Invest 2001, 108:1141-1150.
14. Lesch K-P, Gross UB, Strauss K, Wolozin BL, Murphy DL, Riederer P: Organization of the human serotonin transporter gene. J Neural Transm 1994, 95:157-162.
15. Celada P, Martin F, Artigas F: Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue. Life Sci 1994, 55:1237-1243.
16. Raleigh MJ, Brammer GL, Ritvo ER, Geller E, McGuire MT, Yuwiler A: Effects of chronic fenfluramine on blood serotonin, cerebrospinal fluid metabolites and behaviour in monkeys. Psychpharmacology 1986, 90:503-508.
17. MacLean M, Herve P, Eddahibi S, Adnot S: 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 2000, 131:161-168.
18. Sato K, Webb S, Tucker A, Rabinovitch M, O'Brien RF, McMurtry IF, Stelzner TJ: Factors influencing the idiopathic development of pulmonary hypertension in the Fawn Hooded rat. Am Rev Respir Dis 1992, 145:793-797.
19. Rothman RB, Redmon B, Raatz SK, Kwong CA, Swanson JE, Bantle JP: Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin. Am J Cardiol 2000, 85: 913-916.
20. Louis WJ: Primary pulmonary hypertension and anorectic drugs. N Engl J Med 1999, 340:482-483.
21. Raiteri M, Bonanno G, Vallebuona F: In vitro and in vivo effects of D-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. J Pharmacol Exp Ther 1995, 273:643-649.
22. Miyata M, Ito M, Sasajima T, Ohira H, Kasukawa R: Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats. Chest 2001, 119:554-561.
23. Blakely RD, Ramamoorthy S, Qian Y, Schroeter S, Bradley CC: Regulation of andidepressant-sensitive serotonin transporters. In Neurotransmitters Transporters: Structure, Function and Regulation. Edited by Reith MEA. NJ: Humana Press Inc; 1996:29-72.
24. Semple-Rowland SL, Mahatme A, Rowland NE: Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAS in rat dorsal raphe. Mol Brain Res 1996, 41:121-127.
25. Lesch K-P, Bengel D, Heils A, Sabol SZ, Greeberg BD, Müller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531.
26. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, Knowles JA: Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000, 67:737-744.
27. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, Trembath RC: Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 2000, 26:81-84.